Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Patients characteristics

From: Incidence and predictors of lower extremity lymphedema after postoperative radiotherapy for prostate cancer

Characteristics

Number of pts (N = 101), (%)

Age at diagnosis (years-old); median (IQR)

65 (58–69)

BMI, kg/m2(median)(IQR)

26.1 (24.4–29)

< 25

33 (32.6)

25–30

51 (50.5)

> 30

17 (16.8)

Comorbidities

Smoke

26 (25.7)

Hypertension

43 (42.5)

Cardiopathies

15 (14.8)

DM

7 (6.9)

Surgery

Radical prostatectomy

31 (30.6)

PLND

70 (69.3)

Lymph node dissection (n)

None

31 (30.6)

< 15

42 (41.5)

> 15

28 (27.7)

Gleason score

6–7

87 (86.1)

8

5 (4.9)

> 8

9 (8.9)

pT stage

1–2

50 (49.59)

3–4

51 (50.5)

pN stage

0

68 (67.3)

1

3 (2.9)

X

30 (29.7)

  1. Abbreviation: pts: patients; IQR: interquartile range; BMI: body mass index; DM: Diabetes mellitus; RP: radical prostatectomy; PLND: pelvic lymph node dissection; pT stage: pathological Tumor stage; pN stage: pathological lymphnodes stage
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us